Publications
19
Citations
1,049
Est. group size
—
Recurring co-author estimate
Active years
18
Publishing since 2008
César Aguilar studies how bacteria, especially soil-dwelling Actinomycetota (a group including Streptomyces), produce specialized chemical compounds called natural products, which include many antibiotics and other bioactive molecules. His work combines genome analysis with laboratory experiments to discover new antibiotics, understand how these biosynthetic pathways evolved, and build databases and software tools that help other researchers find and annotate these gene clusters. This research is relevant to students interested in microbiology, genomics, bioinformatics, and drug discovery.
Publication output was low or absent in the mid-2010s to early 2020s but has grown noticeably in the last two years (2024-2025), suggesting increasing recent activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- MITE: the Minimum Information about a Tailoring Enzyme database for capturing specialized metabolite biosynthesis
ChemRxiv · 2025
- MicroAgroBiome: a toolkit for exploring specialized metabolism and ecological interactions in rhizosphere microbiomes of cultivated crops
Nucleic Acids Research · 2025
- Biodiscovery of Actinomycetota through metabolo-genomics reveals functional diversity across contrasting Mexican ecosystems
Microbial Genomics · 2025
- MITE: the Minimum Information about a Tailoring Enzyme database for capturing specialized metabolite biosynthesis
Nucleic Acids Research · 2025
- Discovery of <i>Streptomyces</i> species CS-62, a novel producer of the <i>Acinetobacter baumannii</i> selective antibiotic factumycin
Journal of Industrial Microbiology & Biotechnology · 2024
- Expression in CHO cells of a bacterial biosynthetic pathway producing a small non-ribosomal peptide aldehyde prevents proteolysis of recombinant proteins
Metabolic Engineering · 2024
- Actinomycetota bioprospecting from ore-forming environments
Microbial Genomics · 2024
- <i>Streptomyces lividans</i> 66 produces a protease inhibitor via a tRNA-utilizing enzyme interacting with a C-minus NRPS
Journal of Industrial Microbiology & Biotechnology · 2023
- Evolutionary Genome Mining for the Discovery and Engineering of Natural Product Biosynthesis
Methods in molecular biology · 2022
- MIBiG 3.0: a community-driven effort to annotate experimentally validated biosynthetic gene clusters
Nucleic Acids Research · 2022
- EvoMining reveals the origin and fate of natural product biosynthetic enzymes
Microbial Genomics · 2019
- Evolutionary dynamics of natural product biosynthesis in bacteria
Natural Product Reports · 2019
- Analysis of differentially upregulated proteins in ptsHIcrr− and rppH− mutants in Escherichia coli during an adaptive laboratory evolution experiment
Applied Microbiology and Biotechnology · 2018
- Nucleic Acids Research×4
- Microbial Genomics×3
- Journal of Industrial Microbiology & Biotechnology×2
- Natural Product Reports×1
- Applied Microbiology and Biotechnology×1
- Jeremy R. Lohman
Medicine · Purdue University West Lafayette
- Kou‐San Ju
Medicine · The Ohio State University
- Qingfei Zheng
Medicine · The Ohio State University
- Jerry Cui
Medicine · The Ohio State University
- Emily A. Smith
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile